Autopsy report · NCT01772056

Efficacy Study of Topical Twice Weekly Fluticasone Treatment to Reduce Relapse in Atopic Dermatitis in Children

“Patient recruitment is very slow, economic grant has ended and the number of patients is enough according to sample size (22 children/ arm).”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 years 1 month after it had already started.
• Ran for about 3 years 3 months before it stopped.
• 54 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Elena Rubio Gomis

Sponsor type

University, hospital or other

Conditions

Dermatitis, Atopic

Interventions

Fluticasone, cream; Placebo,

Participants

54

Sites

4

Countries

Spain

Trials that died the same way

• Growth Hormone in Poor Responders to IVF Trial
  “Insufficient/slow patient recruitment” (79% match in meaning)
• Phosphodiesterase (PDE) Inhibitors Effect on Cognitive Deficits Associated to Schizophrenia
  “Patient recruitment insufficient” (78% match in meaning)
• Fesoterodine on Urgency Episodes in Parkinson's Disease Population
  “Insufficient or untimely patient recruitment” (78% match in meaning)
• Bosentan for Treatment of Hepatopulmonary Syndrome in Patients With Liver Cirrhosis
  “too slow patient recruitment” (77% match in meaning)
• Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL)
  “Low rate of patient recruitment. Cannot achieve sample size.” (76% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.